Nature Clinical Practice Rheumatology
(ISSN: 1745-8382, 1745-8390)
For more current articles, go to Nature Reviews Rheumatology
Show only:
Full-text on Medscape | Journal CME
2009 - 5 (3)
- Potential new drug targets for osteoporosis.
- New approaches for managing antiphospholipid syndrome.
- Imaging the painful osteoarthritic knee joint: what have we learned?
- Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside.
- Time for new outcome measures in hand osteoarthritis?
- Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?
- Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?
- How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?
- Is arthroscopic surgery a beneficial treatment for knee osteoarthritis?
- Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP.
- Available therapeutic options following failure of a first anti-TNF agent.
- Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis.
- Certolizumab pegol--what role does this new TNF inhibitor have in the treatment of RA?
- A new 5-lipoxygenase inhibitor seems to be safe and effective for the treatment of osteoarthritis.
- Are static resting wrist splints beneficial in early RA?
